Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 71,794 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| TC BioPharm Holdings PLC | TCBP | NASDAQ | Depository Receipt |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.04 | -2.55% | 1.53 | 23:00:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.58 | 1.51 | 1.63 | 1.53 | 1.57 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 405 | 71,794 | 1.55 | 111,571 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:36:56 | 91 | 1.57 | USD |
TC BioPharm Holdings PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.45M | 950.00k | - | 3.85M | -1.39M | -1.46 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News TC BioPharm
| Date | Time | Source | Heading |
|---|---|---|---|
| 4/04/2024 | 07:32 | PR Newswire (US) | TCBP Announces Execution of Non-Binding Letter of Intent for.. |
| 4/02/2024 | 07:30 | PR Newswire (US) | TCBP Increasing Treatment Capacity with Expanded.. |
| 3/19/2024 | 07:30 | PR Newswire (US) | TCBP Adjourns General Meeting Until a Later Date |
| 3/18/2024 | 07:30 | PR Newswire (US) | TCBP Announces Exercise of Series D Warrants For Cash |
| 3/06/2024 | 05:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/01/2024 | 07:30 | PR Newswire (US) | Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated.. |
| 2/27/2024 | 16:15 | PR Newswire (US) | /C O R R E C T I O N -- TC BioPharm/ |
| 2/27/2024 | 07:30 | PR Newswire (US) | TCBP Announces Shareholder Update Call on March 5th 2024 |
| 2/22/2024 | 08:32 | PR Newswire (US) | TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK.. |
| 2/20/2024 | 05:05 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 2/15/2024 | 07:30 | PR Newswire (US) | TC BioPharm Management to Participate at Upcoming 7th.. |
| 2/14/2024 | 13:48 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
TCBP Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. |
